Observational studyPediatrics international : official journal of the Japan Pediatric Society
Growth and Neurodevelopment to 18 Months in Infant With Varying sn-2 Palmitate Levels in Formula: An Observational Study.
Observational study in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundSn-2 palmitate is a unique lipid found in breast milk that enhances the absorption of palmitic acid (PA) and prevents the soaping of PA in the gut. Feeding formulas with high sn-2 palmitate levels influences infant growth and neurodevelopment; however, few studies have evaluated the long-term effects on these outcomes. In this study, we evaluated the association between feeding formula and exposure to different levels of sn-2 palmitate in infancy and growth or neurodevelopment in infants after 6 months.
methodsThis study was conducted as a follow-up of 1-month-old infants included in a previous study. Infant formulas commercially available in Japan were classified as either high sn-2 formula (PA sn-2 ratio ≥ 50%) or low sn-2 formula (< 50%). The associations between the feeding volume of high/low sn-2 formula at 1 and 6 months of age and anthropometric z-scores or neurodevelopment (Ages & Stages Questionnaires, third edition; ASQ-3) scores at 9 and 18 months were evaluated.
resultsMultiple regression analysis of anthropometric z-scores showed no significant association with feeding with either the low or high sn-2 formulas. Multiple regression analysis of the ASQ-3 scores showed that the communication score at 18 months was negatively associated with feeding with the low sn-2 formula at 1 month, with no association observed for the high sn-2 formula.
conclusionsCompared with the formula with low sn-2 palmitate, feeding formulas with high sn-2 palmitate at 1 month had a lower association with reduced neurodevelopment at 18 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.